ISSN: 2329-6887
Opinión
Phase 0 Clinical Preliminaries in Oncology New Medication Advancement
Mini revisión
Ways to deal with Phase 1 Clinical Trial Design Focused on Safety, Efficiency and Selected Patient Populations: A Report from the Clinical Trial Design Task Force of the National Cancer Institute Investigational Drug Steering Committee